Crossmark

CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic `window of opportunity'

Crossref DOI link: https://doi.org/10.1186/s13075-014-0434-z

Published Online: 2014-09-24

Published Print: 2014-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Greisen, Stinne Ravn

Schelde, Karen Kræmmer

Rasmussen, Tue Kruse

Kragstrup, Tue Wenzel

Stengaard-Pedersen, Kristian

Hetland, Merete Lund

Hørslev-Petersen, Kim

Junker, Peter

Østergaard, Mikkel

Deleuran, Bent

Hvid, Malene
License Information

License valid from 2014-09-24